Biology of Blood and Marrow Transplantation
Volume 14, Issue 12 , Pages 1373-1379 , December 2008

Early Recovery of CD4 T Cell Receptor Diversity after “Lymphoablative” Conditioning and Autologous CD34 Cell Transplantation

  • Jan Storek

      Affiliations

    • Fred Hutchinson Cancer Research Center and University of Washington, Seattle, Washington
    • Department of Medicine, University of Calgary, Calgary, Alberta, Canada
    • Corresponding Author InformationCorrespondence and reprint requests: Jan Storek, MD, PhD, University of Calgary, 3330 Hospital Drive NW, HSC 1869, Calgary, Alberta, Canada T2N 4N1.
    • ,
  • Zhao Zhao

      Affiliations

    • Fred Hutchinson Cancer Research Center and University of Washington, Seattle, Washington
    • ,
  • Yiping Liu

      Affiliations

    • Department of Medicine, University of Calgary, Calgary, Alberta, Canada
    • ,
  • Richard Nash

      Affiliations

    • Fred Hutchinson Cancer Research Center and University of Washington, Seattle, Washington
    • ,
  • Peter McSweeney

      Affiliations

    • Fred Hutchinson Cancer Research Center and University of Washington, Seattle, Washington
    • Rocky Mountain Cancer Center, Denver, Colorado
    • ,
  • David G. Maloney

      Affiliations

    • Fred Hutchinson Cancer Research Center and University of Washington, Seattle, Washington

Received 15 August 2008 ,Accepted 14 September 2008.

References 

  1. Villers D, Milpied N, Gaschet J, et al. Alteration of the T cell repertoire after bone marrow transplantation. Bone Marrow Transplant. 1994;13:19–26
  2. Gorski J, Yassai M, Keever C, et al. Analysis of reconstitution T cell receptor repertoires in bone marrow transplant recipients. Arch Immunol Ther Exp (Warsz). 1995;43:93–97
  3. Gorochov G, Debre P, Leblond V, et al. Oligoclonal expansion of CD8+CD57+ T cells with restricted T cell receptor beta chain variability after bone marrow transplantation. Blood. 1994;83:587–595
  4. Gaschet J, Denis C, Milpied N, et al. Alterations of T cell repertoire after bone marrow transplantation: characterization of over-represented subsets. Bone Marrow Transplant. 1995;16:427–435
  5. Masuko K, Kato S, Hagihara M, et al. Stable clonal expansion of T cells induced by bone marrow transplantation. Blood. 1996;87:789–799
  6. Smith FS, Rencher SD, Heslop HE, et al. T cell receptor repertoire of CD4+ and CD8+ T cell subsets in the allogeneic bone marrow transplant recipients. Cancer Immunol Immunother. 1995;41:104–110
  7. Roux E, Helg C, Chapuis B, et al. T cell repertoire complexity after allogeneic bone marrow transplantation. Hum Immunol. 1996;48:135–138
  8. Roux E, Helg C, Dumont-Girard F, et al. Analysis of T cell repopulation after bone marrow transplantation: significant differences between recipients of T cell depleted and unmanipulated grafts. Blood. 1996;87:3984–3992
  9. Kubo K, Yamanaka K, Kiyoi H, et al. Different T cell receptor repertoires between lesions and peripheral blood in acute GVHD after allogeneic bone marrow transplantation. Blood. 1996;87:3019–3026
  10. Liu X, Chesnokova V, Forman SJ, et al. Molecular analysis of T cell receptor repertoire in bone marrow transplant recipients: evidence of oligoclonal T cell expansion in GVHD lesions. Blood. 1996;87:3032–3044
  11. Vavassori M, Maccario R, Moretta A, et al. Restricted TCR repertoire and long-term persistence of donor-derived antigen-experienced CD4 T cells in allogeneic bone marrow transplantation recipients. J Immunol. 1996;157:5739–5747
  12. Akatsuka Y, Cerveny C, Hansen JA. T cell receptor clonal diversity following allogeneic marrow grafting. Hum Immunol. 1996;48:125–134
  13. Bomberger C, Singh-Jairam M, Rodey G, et al. Lymphoid reconstitution after autologous PBSC transplantation with FACS-sorted CD34+ hematopoietic progenitors. Blood. 1998;91:2588–2600
  14. Wu CJ, Chillemi A, Alyea EP, et al. Reconstitution of T-cell receptor repertoire diversity following T-cell–depleted allogeneic bone marrow transplantation is related to hematopoietic chimerism. Blood. 2000;95:352–359
  15. Godthelp BC, van Tol MJ, Vossen JM, et al. T-cell immune reconstitution in pediatric leukemia patients after allogeneic bone marrow transplantation with T-cell–depleted or unmanipulated grafts: evaluation of overall and antigen-specific T-cell repertoires. Blood. 1999;94:4358–4369
  16. Dumont-Girard F, Roux E, van Lier RA, et al. Reconstitution of the T-cell compartment after bone marrow transplantation: restoration of the repertoire by thymic emigrants. Blood. 1998;92:4464–4471
  17. Verfuerth S, Peggs K, Vyas P, et al. Longitudinal monitoring of immune reconstitution by CDR3 size spectratyping after T-cell–depleted allogeneic bone marrow transplant and the effect of donor lymphocyte infusions on T-cell repertoire. Blood. 2000;95:3990–3995
  18. Bellucci R, Alyea EP, Weller E, et al. Immunologic effects of prophylactic donor lymphocyte infusion after allogeneic marrow transplantation for multiple myeloma. Blood. 2002;99:4610–4617
  19. Claret EJ, Alyea EP, Orsini E, et al. Characterization of T cell repertoire in patients with graft-versus-leukemia after donor lymphocyte infusion. J Clin Invest. 1997;100:855–866
  20. Eyrich M, Croner T, Leiler C, et al. Distinct contributions of CD4(+) and CD8(+) naive and memory T-cell subsets to overall T-cell receptor repertoire complexity following transplantation of T-cell–depleted CD34-selected hematopoietic progenitor cells from unrelated donors. Blood. 2002;100:1915–1918
  21. Friedman TM, Azhipa O, Zilberberg J, et al. Reconstitution of T cell subset repertoire diversity following multiple antigen-mismatched bone marrow transplantation. Biol Blood Marrow Transplant. 2006;12:1092–1095
  22. Roux E, Dumont-Girard F, Starobinski M, et al. Recovery of immune reactivity after T-cell–depleted bone marrow transplantation depends on thymic activity. Blood. 2000;96:2299–2303
  23. Talvensaari K, Clave E, Douay C, et al. A broad T-cell repertoire diversity and an efficient thymic function indicate a favorable long-term immune reconstitution after cord blood stem cell transplantation. Blood. 2002;99:1458–1464
  24. Douek DC, Vescio RA, Betts MR, et al. Assessment of thymic output in adults after haematopoietic stem cell transplantation and prediction of T-cell reconstitution. Lancet. 2000;355:1875–1881
  25. Muraro PA, Douek DC, Packer A, et al. Thymic output generates a new and diverse TCR repertoire after autologous stem cell transplantation in multiple sclerosis patients. J Exp Med. 2005;201:805–816
  26. Protheroe AS, Pickard C, Johnson PW, et al. Persistence of clonal T-cell expansions following high-dose chemotherapy and autologous peripheral blood progenitor cell rescue. Br J Haematol. 2000;111:766–773
  27. McSweeney PA, Nash RA, Sullivan KM, et al. High-dose immunosuppressive therapy for severe systemic sclerosis: initial outcomes. Blood. 2002;100:1602–1610
  28. Nash RA, Bowen JD, McSweeney PA, et al. High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis. Blood. 2003;102:2364–2372
  29. Storek J, Zhao Z, Lin E, et al. Recovery from and consequences of severe iatrogenic lymphopenia (induced to treat autoimmune diseases). Clin Immunol. 2004;113:285–298
  30. Arstila TP, Casrouge A, Baron V, et al. A direct estimate of the human alphabeta T cell receptor diversity. Science. 1999;286:958–961
  31. Del Galdo F, Artlett CM. T cells and B cells in the pathogenesis of systemic sclerosis: recent insights and therapeutic opportunities. Curr Rheumatol Rep. 2006;8:123–130
  32. Frohman EM, Racke MK, Raine CS. Multiple sclerosis: the plaque and its pathogenesis. N Engl J Med. 2006;354:942–955
  33. Kim DH, Sohn SK, Won DI, et al. Rapid helper T-cell recovery above 200 × 106/L at 3 months correlates to successful transplant outcomes after allogeneic stem cell transplantation. Bone Marrow Transplant. 2006;37:1119–1128
  34. Storek J, Gooley T, Witherspoon RP, et al. Infectious morbidity in long-term survivors of allogeneic marrow transplantation is associated with low CD4 T cell counts. Am J Hematol. 1997;54:131–138
  35. Lefranc M-P, Lefranc G. The T Cell Receptor FactsBook. San Diego: Academic Press; 2001;
  36. Gratwohl A, Passweg J, Bocelli-Tyndall C, et al. Autologous hematopoietic stem cell transplantation for autoimmune diseases. Bone Marrow Transplant. 2005;35:869–879
  37. Moore J, Brooks P, Milliken S, et al. A pilot randomized trial comparing CD34-selected versus unmanipulated hemopoietic stem cell transplantation for severe, refractory rheumatoid arthritis. Arthritis Rheum. 2002;46:2301–2309
  38. Zhang H, Chua KS, Guimond M, et al. Lymphopenia and interleukin-2 therapy alter homeostasis of CD4+CD25+ regulatory T cells. Nat Med. 2005;11:1238–1243
  39. de Kleer I, Vastert B, Klein M, et al. Autologous stem cell transplantation for autoimmunity induces immunologic self-tolerance by reprogramming autoreactive T cells and restoring the CD4+CD25+ immune regulatory network. Blood. 2006;107:1696–1702
  40. St Clair EW, Tedder TF. New prospects for autoimmune disease therapy: B cells on deathwatch. Arthritis Rheum. 2006;54:1–9
  41. Packer AN, Muraro PA. Optimized clonotypic analysis of T-cell receptor repertoire in immune reconstitution. Exp Hematol. 2007;35:516–521

 Financial disclosure: See Acknowledgments on page 1378.

PII: S1083-8791(08)00404-7

doi: 10.1016/j.bbmt.2008.09.013

Biology of Blood and Marrow Transplantation
Volume 14, Issue 12 , Pages 1373-1379 , December 2008

Article Tools

* Image Usage & Resolution